It is apparent that study of the mechanisms of action of PDE4 drugs in a variety of human diseases, including lung disease, has enabled progress on understanding fundamental disease mechanisms in COPD and pulmonary fibrosis. This evidence concerns the gene PDE4A and chronic obstructive pulmonary disease.